In addition, percentages of both central memory (CD27+CD45RO+) and effector (CD27−CD45RO−) cells were not different between TB-IRIS and non-IRIS patients at pre-ART as well as at week 2–6 post-ART initiation (Fig. 1). The gene discussed is CD27; the disease is tuberculosis.